Claudia Stefanutti - Concepedia

Author

Claudia Stefanutti

Policlinico Umberto I ORCID

Also Known As

Aleksandr B. Shek, C Stefanutti, C. STEFANUTTI, C. Stefanutti, Claudia STEFANUTTI, Claudia Stefanutti, Daniel Soffer

150

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Policlinico Umberto I Sapienza University of Rome Université de Montréal Amsterdam UMC Location University of Amsterdam University of Palermo

About

Claudia Stefanutti is an author at Policlinico Umberto I specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	1.4K
2	Public Health	9	9	303
3	Health Sciences	6	6	153
4	Biochemistry	1	1	11
5	Blood Transplantation	1	1	35

Claudia Stefanutti

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron, The Lancet Metabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolaemiaCardiovascular DiseaseMedicine	2012	728
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh, New England Journal of Medicine	2020	180
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) Fjolla Zhubi Bakija, Gani Bajraktari, Ibadete Bytyçi, Clinical Nutrition	2020	130
Therapeutic Plasma Exchange in Patients With Severe Hypertriglyceridemia: A Multicenter Study Claudia Stefanutti, S. Di Giacomo, A. Vivenzio, Artificial Organs	2009	84
The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia G. Kees Hovingh, Loek P. Smits, Claudia Stefanutti, American Heart Journal Vascular DiseaseHomozygous Familial HypercholesterolemiaCardiovascular DiseaseHyperlipidemiaVascular Biology	2015	66
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia G. Kees Hovingh, Frederick J. Raal, Ricardo Dent, Journal of clinical lipidology Lipid DisorderHeterozygous Familial HypercholesterolemiaCardiovascular DiseaseInherited Metabolic DiseaseHyperlipidemia	2017	58
Hypercholesterolaemia – practical information for non-specialists Handrean Soran, Safwaan Adam, Jamal B. Mohammad, Archives of Medical Science	2018	57
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia Joep C. Defesche, Claudia Stefanutti, Gisle Langslet, Journal of clinical lipidology	2017	53
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia Merel L. Hartgers, Joep C. Defesche, Gisle Langslet, Journal of clinical lipidology	2017	52
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy Daniel Gaudet, Susanne Greber‐Platzer, Laurens F. Reeskamp, European Heart Journal	2024	52

Page 1